{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:14:12Z","timestamp":1760055252442,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroent\u00e9rologie Clinique et Biologique"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.gcb.2008.01.003","type":"journal-article","created":{"date-parts":[[2008,3,6]],"date-time":"2008-03-06T18:49:50Z","timestamp":1204829390000},"page":"162-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["N\u00e9vrite optique r\u00e9trobulbaire au cours d\u2019un traitement par infliximab pour une rectocolite h\u00e9morragique"],"prefix":"10.1016","volume":"32","author":[{"given":"R.","family":"Hejazi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-F.","family":"Colombel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Peyrin-Biroulet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gcb.2008.01.003_bib1","unstructured":"European Medicines Agency (EMEA). European Public Assessment Report. Procedural steps taken and scientific information after authorisation).Annexe I. R\u00e9sum\u00e9 des caract\u00e9ristiques du produit R\u00e9micade\u00ae\u00a0: www.emea.europa.eu\/."},{"key":"10.1016\/j.gcb.2008.01.003_bib2","doi-asserted-by":"crossref","first-page":"W34","DOI":"10.7326\/0003-4819-140-8-200404200-00037-w4","article-title":"Retrobulbar optic neuritis associated with infliximab in a patient with Crohn disease","volume":"140","author":"Strong","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gcb.2008.01.003_bib3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0181-5512(05)81044-7","article-title":"Optic neuritis associated with infliximab","volume":"28","author":"Tran","year":"2005","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.gcb.2008.01.003_bib4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/bmj.326.7389.579","article-title":"Bilateral anterior toxic optic neuropathy and the use of infliximab","volume":"326","author":"Ten Tusscher","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.gcb.2008.01.003_bib5","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gcb.2008.01.003_bib6","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1053\/j.gastro.2005.06.022","article-title":"Increased risk for demyelinating diseases in patients with inflammatory bowel disease","volume":"129","author":"Gupta","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2008.01.003_bib7","first-page":"S134","article-title":"Demyelination and inhibition of tumor necrosis factor (TNF)","volume":"22","author":"Magnano","year":"2004","journal-title":"Clin Exp Rheumatol"}],"container-title":["Gastroent\u00e9rologie Clinique et Biologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399832008000250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399832008000250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:46:07Z","timestamp":1759974367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399832008000250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0399832008000250"],"URL":"https:\/\/doi.org\/10.1016\/j.gcb.2008.01.003","relation":{},"ISSN":["0399-8320"],"issn-type":[{"type":"print","value":"0399-8320"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N\u00e9vrite optique r\u00e9trobulbaire au cours d\u2019un traitement par infliximab pour une rectocolite h\u00e9morragique","name":"articletitle","label":"Article Title"},{"value":"Gastroent\u00e9rologie Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gcb.2008.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}